Guy Ofir

Insider Reports History

Location
Karmiel, Israel
Signature
/s/ Guy Ofir
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Guy Ofir:

Company Role Class Num Shares Value Price $ Report Date Ownership
Raphael Pharmaceutical Inc. Chief Financial Officer, Director Common Stock 1,266,455 $633,228 $0.5000 26 Jul 2022 Direct
Raphael Pharmaceutical Inc. Chief Financial Officer, Director Warrants to Purchase Common Stock 1,000,000 05 Dec 2022 Direct

Insider Reports Filed by Guy Ofir

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RAPH Raphael Pharmaceutical Inc. 26 Jul 2022 2 $0 4 Chief Financial Officer, Director 13 Mar 2023, 16:01
NONE Raphael Pharmaceutical Inc. 27 Sep 2021 0 $0 3 Chief Financial Officer, Director 19 Nov 2021, 11:51